nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Vulvovaginal pruritus—Progesterone—uterine cancer	0.11	0.115	CcSEcCtD
Terconazole—Vulvovaginal pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0995	0.104	CcSEcCtD
Terconazole—Ketoconazole—CYP11A1—uterine cancer	0.0282	0.659	CrCbGaD
Terconazole—Dysmenorrhoea—Progesterone—uterine cancer	0.0264	0.0275	CcSEcCtD
Terconazole—Dysmenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0239	0.025	CcSEcCtD
Terconazole—Influenza like illness—Progesterone—uterine cancer	0.0233	0.0243	CcSEcCtD
Terconazole—Face oedema—Progesterone—uterine cancer	0.0168	0.0176	CcSEcCtD
Terconazole—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.0152	0.0159	CcSEcCtD
Terconazole—Ketoconazole—CYP19A1—uterine cancer	0.0146	0.341	CrCbGaD
Terconazole—Pain—Carboplatin—uterine cancer	0.0139	0.0145	CcSEcCtD
Terconazole—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.0134	0.014	CcSEcCtD
Terconazole—Body temperature increased—Carboplatin—uterine cancer	0.0129	0.0134	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.0111	0.0116	CcSEcCtD
Terconazole—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00979	0.0102	CcSEcCtD
Terconazole—Ill-defined disorder—Progesterone—uterine cancer	0.00972	0.0102	CcSEcCtD
Terconazole—Malaise—Progesterone—uterine cancer	0.00945	0.00987	CcSEcCtD
Terconazole—Myalgia—Progesterone—uterine cancer	0.00892	0.00932	CcSEcCtD
Terconazole—Arthralgia—Progesterone—uterine cancer	0.00892	0.00932	CcSEcCtD
Terconazole—Discomfort—Progesterone—uterine cancer	0.00882	0.00921	CcSEcCtD
Terconazole—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00881	0.0092	CcSEcCtD
Terconazole—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00856	0.00895	CcSEcCtD
Terconazole—Anaphylactic shock—Progesterone—uterine cancer	0.00855	0.00894	CcSEcCtD
Terconazole—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00808	0.00845	CcSEcCtD
Terconazole—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00808	0.00845	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00802	0.00837	CcSEcCtD
Terconazole—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00799	0.00834	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00779	0.00814	CcSEcCtD
Terconazole—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00775	0.0081	CcSEcCtD
Terconazole—Chills—Dactinomycin—uterine cancer	0.00764	0.00798	CcSEcCtD
Terconazole—Bronchospasm—Etoposide—uterine cancer	0.00757	0.00791	CcSEcCtD
Terconazole—Pain—Progesterone—uterine cancer	0.00731	0.00764	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00706	0.00738	CcSEcCtD
Terconazole—Feeling abnormal—Progesterone—uterine cancer	0.00705	0.00736	CcSEcCtD
Terconazole—Gastrointestinal pain—Progesterone—uterine cancer	0.00699	0.00731	CcSEcCtD
Terconazole—Ill-defined disorder—Dactinomycin—uterine cancer	0.00687	0.00718	CcSEcCtD
Terconazole—Urticaria—Progesterone—uterine cancer	0.00679	0.0071	CcSEcCtD
Terconazole—Abdominal pain—Progesterone—uterine cancer	0.00676	0.00706	CcSEcCtD
Terconazole—Body temperature increased—Progesterone—uterine cancer	0.00676	0.00706	CcSEcCtD
Terconazole—Malaise—Dactinomycin—uterine cancer	0.00668	0.00698	CcSEcCtD
Terconazole—Influenza like illness—Epirubicin—uterine cancer	0.00668	0.00697	CcSEcCtD
Terconazole—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00639	0.00667	CcSEcCtD
Terconazole—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00634	0.00662	CcSEcCtD
Terconazole—Myalgia—Dactinomycin—uterine cancer	0.00631	0.00659	CcSEcCtD
Terconazole—Hypersensitivity—Progesterone—uterine cancer	0.0063	0.00658	CcSEcCtD
Terconazole—Discomfort—Dactinomycin—uterine cancer	0.00623	0.00651	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—uterine cancer	0.00618	0.00645	CcSEcCtD
Terconazole—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00616	0.00643	CcSEcCtD
Terconazole—Asthenia—Progesterone—uterine cancer	0.00614	0.00641	CcSEcCtD
Terconazole—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00613	0.0064	CcSEcCtD
Terconazole—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00613	0.0064	CcSEcCtD
Terconazole—Pruritus—Progesterone—uterine cancer	0.00605	0.00632	CcSEcCtD
Terconazole—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00571	0.00597	CcSEcCtD
Terconazole—Dizziness—Progesterone—uterine cancer	0.00566	0.00591	CcSEcCtD
Terconazole—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00556	0.00581	CcSEcCtD
Terconazole—Chills—Etoposide—uterine cancer	0.00553	0.00577	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00551	0.00575	CcSEcCtD
Terconazole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00548	0.00573	CcSEcCtD
Terconazole—Vomiting—Progesterone—uterine cancer	0.00544	0.00568	CcSEcCtD
Terconazole—Rash—Progesterone—uterine cancer	0.00539	0.00563	CcSEcCtD
Terconazole—Dermatitis—Progesterone—uterine cancer	0.00539	0.00563	CcSEcCtD
Terconazole—Headache—Progesterone—uterine cancer	0.00536	0.0056	CcSEcCtD
Terconazole—Pain—Dactinomycin—uterine cancer	0.00517	0.0054	CcSEcCtD
Terconazole—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00513	0.00535	CcSEcCtD
Terconazole—Nausea—Progesterone—uterine cancer	0.00508	0.00531	CcSEcCtD
Terconazole—Feeling abnormal—Dactinomycin—uterine cancer	0.00498	0.0052	CcSEcCtD
Terconazole—Ill-defined disorder—Etoposide—uterine cancer	0.00497	0.0052	CcSEcCtD
Terconazole—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00494	0.00516	CcSEcCtD
Terconazole—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00493	0.00515	CcSEcCtD
Terconazole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00489	0.00511	CcSEcCtD
Terconazole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00488	0.0051	CcSEcCtD
Terconazole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00486	0.00507	CcSEcCtD
Terconazole—Malaise—Etoposide—uterine cancer	0.00483	0.00505	CcSEcCtD
Terconazole—Face oedema—Epirubicin—uterine cancer	0.00482	0.00503	CcSEcCtD
Terconazole—Abdominal pain—Dactinomycin—uterine cancer	0.00478	0.00499	CcSEcCtD
Terconazole—Body temperature increased—Dactinomycin—uterine cancer	0.00478	0.00499	CcSEcCtD
Terconazole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0046	0.00481	CcSEcCtD
Terconazole—Discomfort—Etoposide—uterine cancer	0.00451	0.00471	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00449	0.00469	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—uterine cancer	0.00446	0.00466	CcSEcCtD
Terconazole—Hypersensitivity—Dactinomycin—uterine cancer	0.00445	0.00465	CcSEcCtD
Terconazole—Anaphylactic shock—Etoposide—uterine cancer	0.00438	0.00457	CcSEcCtD
Terconazole—Asthenia—Dactinomycin—uterine cancer	0.00434	0.00453	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00416	0.00434	CcSEcCtD
Terconazole—Vomiting—Dactinomycin—uterine cancer	0.00384	0.00402	CcSEcCtD
Terconazole—Rash—Dactinomycin—uterine cancer	0.00381	0.00398	CcSEcCtD
Terconazole—Pain—Etoposide—uterine cancer	0.00374	0.00391	CcSEcCtD
Terconazole—Feeling abnormal—Etoposide—uterine cancer	0.00361	0.00377	CcSEcCtD
Terconazole—Nausea—Dactinomycin—uterine cancer	0.00359	0.00375	CcSEcCtD
Terconazole—Gastrointestinal pain—Etoposide—uterine cancer	0.00358	0.00374	CcSEcCtD
Terconazole—Urticaria—Etoposide—uterine cancer	0.00348	0.00363	CcSEcCtD
Terconazole—Abdominal pain—Etoposide—uterine cancer	0.00346	0.00361	CcSEcCtD
Terconazole—Body temperature increased—Etoposide—uterine cancer	0.00346	0.00361	CcSEcCtD
Terconazole—Hypersensitivity—Etoposide—uterine cancer	0.00322	0.00337	CcSEcCtD
Terconazole—Asthenia—Etoposide—uterine cancer	0.00314	0.00328	CcSEcCtD
Terconazole—Chills—Epirubicin—uterine cancer	0.0031	0.00324	CcSEcCtD
Terconazole—Pruritus—Etoposide—uterine cancer	0.0031	0.00323	CcSEcCtD
Terconazole—Dizziness—Etoposide—uterine cancer	0.00289	0.00302	CcSEcCtD
Terconazole—Chills—Doxorubicin—uterine cancer	0.00287	0.00299	CcSEcCtD
Terconazole—Ill-defined disorder—Epirubicin—uterine cancer	0.00279	0.00291	CcSEcCtD
Terconazole—Vomiting—Etoposide—uterine cancer	0.00278	0.00291	CcSEcCtD
Terconazole—Rash—Etoposide—uterine cancer	0.00276	0.00288	CcSEcCtD
Terconazole—Dermatitis—Etoposide—uterine cancer	0.00276	0.00288	CcSEcCtD
Terconazole—Headache—Etoposide—uterine cancer	0.00274	0.00286	CcSEcCtD
Terconazole—Malaise—Epirubicin—uterine cancer	0.00271	0.00283	CcSEcCtD
Terconazole—Nausea—Etoposide—uterine cancer	0.0026	0.00271	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—uterine cancer	0.00258	0.0027	CcSEcCtD
Terconazole—Myalgia—Epirubicin—uterine cancer	0.00256	0.00267	CcSEcCtD
Terconazole—Arthralgia—Epirubicin—uterine cancer	0.00256	0.00267	CcSEcCtD
Terconazole—Discomfort—Epirubicin—uterine cancer	0.00253	0.00264	CcSEcCtD
Terconazole—Malaise—Doxorubicin—uterine cancer	0.00251	0.00262	CcSEcCtD
Terconazole—Anaphylactic shock—Epirubicin—uterine cancer	0.00245	0.00256	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—uterine cancer	0.00237	0.00247	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—uterine cancer	0.00237	0.00247	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—uterine cancer	0.00234	0.00244	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—uterine cancer	0.00227	0.00237	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00223	0.00233	CcSEcCtD
Terconazole—Pain—Epirubicin—uterine cancer	0.0021	0.00219	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00207	0.00216	CcSEcCtD
Terconazole—Feeling abnormal—Epirubicin—uterine cancer	0.00202	0.00211	CcSEcCtD
Terconazole—Gastrointestinal pain—Epirubicin—uterine cancer	0.00201	0.0021	CcSEcCtD
Terconazole—Urticaria—Epirubicin—uterine cancer	0.00195	0.00204	CcSEcCtD
Terconazole—Pain—Doxorubicin—uterine cancer	0.00194	0.00203	CcSEcCtD
Terconazole—Body temperature increased—Epirubicin—uterine cancer	0.00194	0.00203	CcSEcCtD
Terconazole—Abdominal pain—Epirubicin—uterine cancer	0.00194	0.00203	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—uterine cancer	0.00187	0.00195	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00186	0.00194	CcSEcCtD
Terconazole—Hypersensitivity—Epirubicin—uterine cancer	0.00181	0.00189	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—uterine cancer	0.0018	0.00188	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—uterine cancer	0.00179	0.00187	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—uterine cancer	0.00179	0.00187	CcSEcCtD
Terconazole—Asthenia—Epirubicin—uterine cancer	0.00176	0.00184	CcSEcCtD
Terconazole—Pruritus—Epirubicin—uterine cancer	0.00174	0.00181	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—uterine cancer	0.00167	0.00175	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—uterine cancer	0.00163	0.0017	CcSEcCtD
Terconazole—Dizziness—Epirubicin—uterine cancer	0.00162	0.00169	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—uterine cancer	0.00161	0.00168	CcSEcCtD
Terconazole—Vomiting—Epirubicin—uterine cancer	0.00156	0.00163	CcSEcCtD
Terconazole—Rash—Epirubicin—uterine cancer	0.00155	0.00162	CcSEcCtD
Terconazole—Dermatitis—Epirubicin—uterine cancer	0.00154	0.00161	CcSEcCtD
Terconazole—Headache—Epirubicin—uterine cancer	0.00154	0.00161	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—uterine cancer	0.0015	0.00157	CcSEcCtD
Terconazole—Nausea—Epirubicin—uterine cancer	0.00146	0.00152	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—uterine cancer	0.00144	0.00151	CcSEcCtD
Terconazole—Rash—Doxorubicin—uterine cancer	0.00143	0.00149	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—uterine cancer	0.00143	0.00149	CcSEcCtD
Terconazole—Headache—Doxorubicin—uterine cancer	0.00142	0.00149	CcSEcCtD
Terconazole—Nausea—Doxorubicin—uterine cancer	0.00135	0.00141	CcSEcCtD
